A bill to amend the Federal Food, Drug, and Cosmetic Act to authorize the use of investigational individualized medical treatments by patients diagnosed with a life-threatening disease or condition or severely debilitating illness, and for other purposes.
Sponsor

- Conservative Groups$1,456k
Full profile: /officials/J000293
Source: Congress.gov · FEC
Cosponsors (1)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
2026-06-08
Source: Congress.gov
Committee Activity
Currently in
- Senate Committee on Health, Education, Labor, and PensionsReferred To · 2026-06-08
Plain-English Summary
This bill would allow patients with serious or life-threatening illnesses to try experimental medical treatments that haven't yet been officially approved by the FDA, even if those treatments are still being tested. The change would give terminally ill or severely sick patients more options when standard treatments aren't working, though they would need to work with their doctors to access these experimental therapies. The bill affects patients with life-threatening conditions, their doctors, and pharmaceutical companies developing new treatments.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- SRES765A resolution expressing support for the designation of July 2026 as "National Sarcoma Awareness Month".Introduced · 2026-06-09
- S1830Right to Treat ActReferred to Committee · 2026-03-19
- S3710SOAR Permanent Authorization ActReferred to Committee · 2026-01-28
- S3168Shutdown Fairness ActIntroduced · 2025-11-10